TIMP3 and breast carcinoma: Taken together, the key findings of our study provide evidence illustrating the role of lncRNA ROR as an oncogene in breast cancer via the recruitment of transmethylase MLL1 to the TIMP3 promoter region, elevating TIMP3 level (Fig. 6).